William Blair Issues Pessimistic Outlook for Neogen Earnings

Neogen Co. (NASDAQ:NEOG - Free Report) - William Blair decreased their FY2025 earnings per share estimates for shares of Neogen in a research note issued to investors on Thursday, April 10th. William Blair analyst B. Vazquez now expects that the company will earn $0.32 per share for the year, down from their prior estimate of $0.38. The consensus estimate for Neogen's current full-year earnings is $0.38 per share. William Blair also issued estimates for Neogen's Q4 2025 earnings at $0.10 EPS and FY2026 earnings at $0.43 EPS.

Neogen (NASDAQ:NEOG - Get Free Report) last released its quarterly earnings results on Wednesday, April 9th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by ($0.02). The company had revenue of $221.00 million during the quarter, compared to analyst estimates of $225.27 million. Neogen had a negative net margin of 52.12% and a positive return on equity of 2.89%. Neogen's revenue was down 3.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.12 EPS.

NEOG has been the topic of a number of other reports. Piper Sandler decreased their price target on shares of Neogen from $13.00 to $6.50 and set a "neutral" rating on the stock in a research note on Monday. Guggenheim decreased their target price on Neogen from $15.00 to $13.00 and set a "buy" rating on the stock in a research report on Thursday, April 10th.

Neogen Price Performance

NEOG traded down $0.21 during midday trading on Monday, hitting $4.39. 12,563,404 shares of the company traded hands, compared to its average volume of 2,636,796. The company has a market capitalization of $952.38 million, a price-to-earnings ratio of -2.00 and a beta of 1.57. The business has a 50 day simple moving average of $8.51 and a two-hundred day simple moving average of $11.60. The company has a current ratio of 3.77, a quick ratio of 2.46 and a debt-to-equity ratio of 0.33. Neogen has a 52-week low of $3.87 and a 52-week high of $18.58.

Insider Activity

In other Neogen news, CAO John Patrick Moylan acquired 10,000 shares of the company's stock in a transaction that occurred on Thursday, April 10th. The stock was bought at an average price of $5.07 per share, with a total value of $50,700.00. Following the purchase, the chief accounting officer now owns 10,000 shares in the company, valued at approximately $50,700. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.13% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Harbour Investments Inc. acquired a new position in Neogen during the fourth quarter worth $27,000. Versant Capital Management Inc increased its position in Neogen by 1,495.4% during the first quarter. Versant Capital Management Inc now owns 3,127 shares of the company's stock worth $27,000 after purchasing an additional 2,931 shares during the last quarter. Blue Trust Inc. raised its stake in Neogen by 196.7% during the fourth quarter. Blue Trust Inc. now owns 3,368 shares of the company's stock worth $41,000 after purchasing an additional 2,233 shares during the period. Johnson Financial Group Inc. acquired a new position in Neogen in the 4th quarter valued at about $43,000. Finally, Covestor Ltd grew its stake in shares of Neogen by 41.4% in the 4th quarter. Covestor Ltd now owns 4,103 shares of the company's stock valued at $50,000 after buying an additional 1,202 shares during the period. 96.73% of the stock is owned by hedge funds and other institutional investors.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.